Skip to Content

Clostri Shield 7 (Canada)

This page contains information on Clostri Shield 7 for veterinary use.
The information provided typically includes the following:
  • Clostri Shield 7 Indications
  • Warnings and cautions for Clostri Shield 7
  • Direction and dosage information for Clostri Shield 7

Clostri Shield 7

This treatment applies to the following species:
Manufacturer: Novartis

Clostridium Chauvoei-Septicum-Novyi-Sordellii-Perfringens Types C & D Bacterin-Toxoid

For Use In Animals Only

Clostri Shield 7 Indications

For use in healthy cattle and sheep as an aid in the prevention of diseases caused by C. chauvoei (blackleg), C. septicum (malignant edema), C. novyi (black disease), C. sordellii (gas-gangrene), and C. perfringens Types B, C, and D (enterotoxemia). Although C. perfringens Type B is not a significant problem in North America the combination of Type C (beta) and Type D (epsilon) toxoid immunizes against disease caused by C. perfringens Type B.

ADJUVANT: Proprietary dual component.

Directions For Use

Shake well before using. For cattle and sheep, administer 2 mL subcutaneously. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (under the skin) in the neck. Revaccinate in 2-4 weeks. Calves vaccinated prior to 3 months of age should be revaccinated at 4-6 months of age or at weaning. Safety and efficacy has been demonstrated in sheep as young as 2 months of age. Revaccinate annually or as recommended by your veterinarian.

Precautions

Store out of direct sunlight at 2°-7°C (35°-45°F). DO NOT FREEZE. Use entire contents when first opened. Do not vaccinate within 21 days prior to slaughter. Vaccination may cause swelling at the injection site and, in sheep, transient lameness. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine.

U.S. Vet. License No. 303

Novartis Animal Health US, Inc.

©2012 Novartis; Registered trademark of Novartis AG, used under license.

Novartis Animal Health Canada Inc., Mississauga, Ontario, Canada L5N 1V9

1-800-387-6325

10 Doses

20 mL

334CA-04

50 Doses

100 mL

 

NAC No.: 1231089.3

ELANCO CANADA LIMITED
Distributed by ELANCO, Division Eli Lilly Canada Inc. & ELANCO CANADA LIMITED (successor to Novartis Animal Health Canada Inc.)
RESEARCH PARK CENTRE, 150 RESEARCH LANE, SUITE 120, GUELPH, ON, N1G 4T2
Telephone:   519-821-0277
Order Desk:   800-773-7603
Fax:   519-821-7831
Elanco Canada Limited Customer Service Telephone:   800-387-6325
Elanco Canada Limited Customer Service Fax:   800-827-5782
Website:   www.Elanco.ca
Every effort has been made to ensure the accuracy of the Clostri Shield 7 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2015 North American Compendiums. Updated: 2015-08-17

Hide